Register for our free email digests:
Latest From MannKind Corp.
Amphastar has inventory for the emergency asthma product but is frustrated by the recent second complete response letter from US FDA seeking additional information. Human factors issued figured into CRLs for both Primatene Mist and intranasal naloxone.
Nanobiotix has made two new appointments – one related to clinical development and the other to investor relations – to its US team.
APPOINTMENT ROUND UP: GlaxoSmithKline, Sanofi, Immune Design, Clinigen, Advaxis, Nanobiotix and Kite Pharma
This week's round up includes CEO appointments by GSK, who has appointed Brian McNamara CEO of the company's consumer unit, Clinigen and The Grünenthal Group; and executive appointments by Sanofi, where Alan Main has joined as executive vice president consumer healthcare global business unit, Immune Design, Advaxis, Kite Pharma and Bavarian Nordic.
This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.
- Medical Devices
- Drug Delivery
- Therapeutic Areas
- Metabolic Disorders
- North America
- Parent & Subsidiaries
- MannKind Corp.
- Senior Management
Matthew J Pfeffer, CEO & CFO
Hakan S Edstrom, Pres. & COO
- Contact Info
Phone: (661) 775-5300
25134 Rye Canyon Loop
Valencia, CA 91355
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.